<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/88E7F128-3C74-41BD-9BEC-A1ED1F36676C"><gtr:id>88E7F128-3C74-41BD-9BEC-A1ED1F36676C</gtr:id><gtr:name>University of Newcastle Australia</gtr:name><gtr:address><gtr:line1>University of Newcastle</gtr:line1><gtr:line2>po bOX 127</gtr:line2><gtr:line4>Ourimbah</gtr:line4><gtr:line5>New South Wales</gtr:line5><gtr:postCode>NSW 2258</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/13270CC5-25E0-4706-9E63-BAA23A1C11B7"><gtr:id>13270CC5-25E0-4706-9E63-BAA23A1C11B7</gtr:id><gtr:name>Telethon Institute for Child Health Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9218106A-E8CE-46A5-AABC-B4C8ED148690"><gtr:id>9218106A-E8CE-46A5-AABC-B4C8ED148690</gtr:id><gtr:name>University of Amsterdam</gtr:name><gtr:address><gtr:line1>Liaison Office</gtr:line1><gtr:line2>PO Box 19268</gtr:line2><gtr:line4>Amsterdam</gtr:line4><gtr:line5>Amsterdam</gtr:line5><gtr:postCode>1000 GG</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7"><gtr:id>05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7</gtr:id><gtr:name>Washington University at St Louis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/88E7F128-3C74-41BD-9BEC-A1ED1F36676C"><gtr:id>88E7F128-3C74-41BD-9BEC-A1ED1F36676C</gtr:id><gtr:name>University of Newcastle Australia</gtr:name><gtr:address><gtr:line1>University of Newcastle</gtr:line1><gtr:line2>po bOX 127</gtr:line2><gtr:line4>Ourimbah</gtr:line4><gtr:line5>New South Wales</gtr:line5><gtr:postCode>NSW 2258</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/13270CC5-25E0-4706-9E63-BAA23A1C11B7"><gtr:id>13270CC5-25E0-4706-9E63-BAA23A1C11B7</gtr:id><gtr:name>Telethon Institute for Child Health Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9218106A-E8CE-46A5-AABC-B4C8ED148690"><gtr:id>9218106A-E8CE-46A5-AABC-B4C8ED148690</gtr:id><gtr:name>University of Amsterdam</gtr:name><gtr:address><gtr:line1>Liaison Office</gtr:line1><gtr:line2>PO Box 19268</gtr:line2><gtr:line4>Amsterdam</gtr:line4><gtr:line5>Amsterdam</gtr:line5><gtr:postCode>1000 GG</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7"><gtr:id>05F17A40-A0E2-4FF2-BC89-81C0CCE9A7D7</gtr:id><gtr:name>Washington University at St Louis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4005F266-447D-4EDA-A4B7-9CA1561F4D0A"><gtr:id>4005F266-447D-4EDA-A4B7-9CA1561F4D0A</gtr:id><gtr:firstName>Onn</gtr:firstName><gtr:otherNames>M</gtr:otherNames><gtr:surname>Kon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6A6BC2D8-CDFF-48E1-ADD7-DDA443526623"><gtr:id>6A6BC2D8-CDFF-48E1-ADD7-DDA443526623</gtr:id><gtr:firstName>Sebastian</gtr:firstName><gtr:otherNames>L</gtr:otherNames><gtr:surname>Johnston</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8C30D034-2BA8-492E-8922-075C5D504940"><gtr:id>8C30D034-2BA8-492E-8922-075C5D504940</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Edwards</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0601236"><gtr:id>74F5EAE4-1152-4247-9871-3B985CD01710</gtr:id><gtr:title>Mechanisms of Deficient Innate Immune Responses in Asthma</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601236</gtr:grantReference><gtr:abstractText>Asthma is the most common chronic respiratory disease in the UK. The majority of healthcare costs are related to acute attacks. Acute attacks are also dreaded by asthma sufferers, as they lead to severe breathlessness, hospitalisation or death. Current therapies are not good at either treatment or prevention of acute attacks. New approaches to therapy are therefore urgently needed. Asthma attacks are caused by common cold viruses, which ?go to the chest?, some are also made worse by chronic bacterial colonisation which can be ?reactivated? during acute attacks. We have discovered asthmatics have weak immune responses to viral and bacterial infections, accounting for their increased susceptibility to these infections. 
We plan to carry out detailed studies of anti-viral and anti-bacterial immunity in lung cells from adults with asthma, to identify the molecules deficient in switching on immune responses in the lung during these attacks. We will also study different forms of asthma to see how widespread these deficiencies are, and will study children through from birth to 6 years of age, to see when these deficiencies develop. Finally we will see if the deficiencies are detected in blood tests so they can be more easily identified.
By identifying the molecules that are deficient during these attacks, we should be able to identify targets for the development of new therapies for both prevention and treatment of acute attack of asthma. So doing would greatly reduce distress suffered by asthma patients, as well as reducing mortality and health care costs.</gtr:abstractText><gtr:technicalSummary>Most asthma morbidity, mortality and health care costs result from acute exacerbations, which are only partially responsive to current therapies. New approaches to treatment are needed. Most exacerbations are associated with rhinovirus infections, but mechanisms of exacerbation are poorly understood. We have reported that atopic asthmatics have increased susceptibility to rhinovirus infection and defective innate immune responses, with deficient rhinovirus-induction of IFN-beta and a novel family of IFNs-lambda1-3 in lower airway cells. Asthmatics also have increased colonisation with Chlamydophila pneumoniae (C.pn) and risk of invasive bacterial infections, C.pn reactivation is linked to asthma exacerbations, alpha/betaIFNs are required for immunity to C.pn, and we have shown LPS induction of IFN-lambda is deficient in asthma. Therefore, IFN deficiency seems an important novel mechanism of increased susceptibility to viral and bacterial infections, which both contribute to asthma exacerbations. Mechanisms of alpha/beta/lambdaIFN deficiency in asthma are unknown ?we seek to understand the mechanisms of deficient IFN production in asthma to identify specific targets for development of new therapies. We need to know whether these deficiencies are asthma/atopy-specific, whether they occur in children and if so, whether they are present at birth or acquired during childhood. We also need to discover if defects are observed in less invasive samples (PBMCs/serum). We hypothesise that IFN deficiency in asthma results from impaired expression/activation of key signalling molecules (from pathogen sensors to transcription factors) required for induction of alpha/beta/lambdaIFNs in response to viral &amp;amp; bacterial infection; that it is a specific feature of asthma (not atopy); it affects cells outside the respiratory tract as well as airway cells and is acquired in the first 5 yrs of life in relation to low exposure to infections (0-3yrs). To investigate these hypotheses, we will study detailed molecular mechanisms of alpha/beta/lambdaIFN induction in response to viral and bacterial infections/stimuli, in primary bronchial epithelial cells, airway macrophages and PBMCs from adults with clearly defined asthma and/or atopy. We will study IFN responses in cells from cord blood and blood taken at 1, 3 &amp;amp; 5 yrs of age in a birth cohort study. IFN production will be related to asthma outcomes determined at 6yrs, and to respiratory infections ascertained in yrs 0-3, along with other relevant risk factors by multiple logistic regression. The proposed studies will identify novel targets for development of new therapies for asthma exacerbations and determine which populations with asthma would be most likely to benefit from new therapies.</gtr:technicalSummary><gtr:fund><gtr:end>2011-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1219727</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Queensland</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Children's Health &amp; Environment Program (CHEP)</gtr:department><gtr:description>Prof Peter Sly, UWA</gtr:description><gtr:id>6CA70EAD-76E8-4558-9E7D-660675D93875</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AstraZeneca</gtr:description><gtr:id>0D21ACD0-A5CD-46F9-BF99-8070C98C9D90</gtr:id><gtr:impact>....</gtr:impact><gtr:partnerContribution>Characterising the molecular defect in interferon production in asthma.</gtr:partnerContribution><gtr:piContribution>Characterising the molecular defect in interferon production in asthma.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Newcastle Australia</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Prof Joerg Mattes, Newcastle</gtr:description><gtr:id>77A4D68E-3CC8-445D-AEC9-984D09508A59</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Washington University at St Louis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Prof Michael J Holtzman, Washington</gtr:description><gtr:id>E58AABC7-30F6-4DE3-B00A-8CB5E8B79504</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Prof Chris Brightling, University of Leicester</gtr:description><gtr:id>3BC55466-4F8B-44CB-909B-BFBC5FCBBF61</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Amsterdam</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>University Medical Center Amsterdam</gtr:department><gtr:description>Prof Rene Lutter, AMC</gtr:description><gtr:id>7B683C3C-BDB0-4C61-B637-738AF4A395EA</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Axel Nohturfft, University of London</gtr:description><gtr:id>5EDCB550-24F1-4B0E-814D-9B2519F272B2</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London (KCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Prof Anne Greenough, King's College London</gtr:description><gtr:id>36533BA3-5D9B-4814-A738-D938EDE9504B</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>Prof Andrew Bush, Imperial College London</gtr:description><gtr:id>059C550A-F84E-4479-8AB4-12E82FF29D9F</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Telethon Institute for Child Health Research</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Division of Cell Biology</gtr:department><gtr:description>Prof Patrick Holt, UWA</gtr:description><gtr:id>65686787-4857-4145-9DA8-1514776E0AFC</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Prof Adnan Custovic, Imperial College London</gtr:description><gtr:id>B6072C4F-36AD-40C8-AC6C-B98B300A6F77</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>Collaboration with Prof Custovic in a study will combining world-leading expertise in infection and immunity, a population based birth cohort study and computational analysis to identify novel mechanisms related to increased susceptibility to asthma, allergies and RTIs.</gtr:partnerContribution><gtr:piContribution>Collaboration with Prof Custovic in a study will combining world-leading expertise in infection and immunity, a population based birth cohort study and computational analysis to identify novel mechanisms related to increased susceptibility to asthma, allergies and RTIs.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Newcastle Australia</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Prof Paul Foster, UCL</gtr:description><gtr:id>E7D77FAE-8ED9-48AB-8FCA-83A9DCD7D2B0</gtr:id><gtr:impact>ongoing collaboration</gtr:impact><gtr:partnerContribution>ongoing collaboration</gtr:partnerContribution><gtr:piContribution>ongoing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GlaxoSmithKline</gtr:description><gtr:id>55D79CE4-5F65-42DF-8847-C1A245C7BE45</gtr:id><gtr:impact>...</gtr:impact><gtr:partnerContribution>Development of an experimental model of rhinovirus induced COPD exacerbation.</gtr:partnerContribution><gtr:piContribution>Development of an experimental model of rhinovirus induced COPD exacerbation.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC Centenary Celebration (Science Festival &amp; Open Week, June 2013)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A28800E8-44C8-44B7-9D5D-30FF48D0EB96</gtr:id><gtr:impact>The Centre took part in the MRC Centenary Celebrations on 15th-16th June 2013 (Science Festival at the Science Museum) and on 20th June 2013, when we organised a day-time event as part of the Centenary Open Week.


Some outcomes of our Open Day event on 20th June 2013 by the Observation Point in London's South Bank:

? 12ft inflatable lungs from The Roy Castle Lung Cancer Foundation were probably our most significant model for the Open Week event. Centre scientists worked in shifts, presenting the anatomy and function of normal lungs and also spoke of lung diseases
? Asthma themed sand sculptures on the banks of Thames were of great interest. MRC Centenary hash tag #100mrc was also drawn in sand
? The desk size balloon model of lungs demonstrated how lungs work in a healthy individual and what happens in the lungs of asthmatics
? Members of the public were introduced to most common allergens at home ('Allergen House' poster game with magnetic allergens). Allergens such as dustmites and mold were placed in rooms where one would most likely encounter them. Afterwards scientists corrected the answers and explained the reasons why
? We ran an interactive game of Respiratory Olympics where peoples' lung capacities were measured using a spirometer. Men and women competed in different categories and the biggest lung capacity in each category won a prize, which was a pair of tickets to the Open East Festival (the first official opening of the Olympic Park since the 2012 Olympics)
? Overall we felt that our event was very well received, judging by the footfall and the fact that we did not experience many quiet moments. We felt that people were interested in our work and found our research of great significance

Other information:

? Collaboration and interaction with our partners (MRC, Asthma UK, Imperial and King's Colleges) as well as the other London based MRC Centres
? The Biomedical Research Centre (BRC) and the British Society for Immunology (BSI)
? Great learning exposure and enthusiasm for the Centre trainees (students and Post Docs)
? Our Open Day event was attended by Dr. Alfred William Frankland, one of the early pioneers of allergen immunotherapy 
? Asthma UK Visit on12th Nov 2013 to the Centre Headquarters. Asthma UK have since requested further events for patients and donors. There are likely to be some as yet unknown impacts.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.centenary.mrc.ac.uk/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2019424</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>P41413 MRC JOHNSTON</gtr:fundingRef><gtr:id>74DEC901-3BD9-407D-9B44-9C3DBE71406F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ERC Advanced Grant</gtr:description><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>4DF95C28-A147-4531-8461-511B3C9EAB4E</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>377932</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PREDICTA Post-infectious immune reprogramming and its association with persistence and chronicity of respiratory allergic diseases (6m euros across 13 participants)</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>F34EE54B-CCF7-4493-90DE-1E43C9D362E7</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1146793</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asthma UK Professorship</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Asthma UK</gtr:fundingOrg><gtr:id>1B852CB2-F536-4CC2-826E-21752897D61A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6133D691-36E8-4C03-BD96-2C05BB14B5FF"><gtr:id>6133D691-36E8-4C03-BD96-2C05BB14B5FF</gtr:id><gtr:title>Soluble major histocompatibility complex class I-related chain B molecules are increased and correlate with clinical outcomes during rhinovirus infection in healthy subjects.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4aa7b01d52e2a7dc88f6a96d74212ea7"><gtr:id>4aa7b01d52e2a7dc88f6a96d74212ea7</gtr:id><gtr:otherNames>Telcian AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6F0D7C0F-5F9F-4F56-B84F-B7AC91D11D31"><gtr:id>6F0D7C0F-5F9F-4F56-B84F-B7AC91D11D31</gtr:id><gtr:title>Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a60e28f2a1214b4efd1d55a151a8fffd"><gtr:id>a60e28f2a1214b4efd1d55a151a8fffd</gtr:id><gtr:otherNames>Beale J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FD40E410-FB16-4A41-96C0-F1C6437F83C0"><gtr:id>FD40E410-FB16-4A41-96C0-F1C6437F83C0</gtr:id><gtr:title>Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/604042224d0125c8a1aec0b0e0124f58"><gtr:id>604042224d0125c8a1aec0b0e0124f58</gtr:id><gtr:otherNames>Gielen V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4CDEF99-A35F-4542-BB56-E58B79D59635"><gtr:id>D4CDEF99-A35F-4542-BB56-E58B79D59635</gtr:id><gtr:title>Impaired innate interferon induction in severe therapy resistant atopic asthmatic children.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8603744bac0fd9c512c0c37ca4382a6a"><gtr:id>8603744bac0fd9c512c0c37ca4382a6a</gtr:id><gtr:otherNames>Edwards MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3D23AF91-BB61-4E6A-8CAE-4C2D40143C31"><gtr:id>3D23AF91-BB61-4E6A-8CAE-4C2D40143C31</gtr:id><gtr:title>TLR3, TLR4 and TLRs7-9 Induced Interferons Are Not Impaired in Airway and Blood Cells in Well Controlled Asthma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6a762cae31c0c74b0b2547e518a2b049"><gtr:id>6a762cae31c0c74b0b2547e518a2b049</gtr:id><gtr:otherNames>Sykes A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/422471A4-2982-4CFE-AE7C-1130BD994C32"><gtr:id>422471A4-2982-4CFE-AE7C-1130BD994C32</gtr:id><gtr:title>Asthma exacerbations: origin, effect, and prevention.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0f4428e74d7e20f063684d7234777b16"><gtr:id>0f4428e74d7e20f063684d7234777b16</gtr:id><gtr:otherNames>Jackson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/234C88E8-A441-4CCD-A1E6-4CF64B2501D9"><gtr:id>234C88E8-A441-4CCD-A1E6-4CF64B2501D9</gtr:id><gtr:title>The microbiology of asthma.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8603744bac0fd9c512c0c37ca4382a6a"><gtr:id>8603744bac0fd9c512c0c37ca4382a6a</gtr:id><gtr:otherNames>Edwards MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82988740-13FD-4692-838B-04FAE9F4775E"><gtr:id>82988740-13FD-4692-838B-04FAE9F4775E</gtr:id><gtr:title>Rhinovirus-induced interferon production is not deficient in well controlled asthma.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6a762cae31c0c74b0b2547e518a2b049"><gtr:id>6a762cae31c0c74b0b2547e518a2b049</gtr:id><gtr:otherNames>Sykes A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4229B83D-1E59-42C1-A917-CBFB68CD127D"><gtr:id>4229B83D-1E59-42C1-A917-CBFB68CD127D</gtr:id><gtr:title>RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells.</gtr:title><gtr:parentPublicationTitle>The European respiratory journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c44c1cda910903d745a90a4e119196e"><gtr:id>0c44c1cda910903d745a90a4e119196e</gtr:id><gtr:otherNames>Zdrenghea MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0903-1936</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601236</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>